Bridgeway Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.45M	Hold	700,000	–	–	0.03%	594
2025 Q1	$1.54M	Buy	700,000 +400,000	+133%	+$880K	0.04%	558
2024 Q4	$459K	Buy	+300,000	New	+$459K	0.01%	834